NASDAQ
Electromedical Technologies, Inc. (EMED) has a price/fcf ratio of -3.92x as of Tuesday, May 26, 2026. This represents a 141.26% decrease compared to its 12-month average of -1.62x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.